Nuvectra Corporation (NVTR) Reports Q2 Loss of $0.85/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Nuvectra Reports Second Quarter 2016 Financial Results
August 10, 2016 4:01 PM EDTPLANO, Texas, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the second quarter ended July 1, 2016.
Recent Accomplishments & Highlights
U.S. sales team now has 28 active territories with approximately 10 territories scheduled to complete training by the end of AugustInitiated U.S. sales of Algovita® Spinal Cord Stimulation SystemEstablished Medical Advisory Board with industry leading physicians to guide clinical and commercial activityEntered into license agreement with Aleva Neurotherapeutics, S.A. to develop Nuvectras neurostimulation... More